What is the catalog number for Cdc37 Rabbit Polyclonal Antibody?

The catalog number for Cdc37 Rabbit Polyclonal Antibody is orb107156.

What sizes are available for Cdc37 Rabbit Polyclonal Antibody?

Cdc37 Rabbit Polyclonal Antibody is available in the following size(s): 100 µg.

Is Cdc37 Rabbit Polyclonal Antibody in stock?

Cdc37 Rabbit Polyclonal Antibody is currently made to order / not held in immediate stock. Contact us for lead time.

Cdc37 Rabbit Polyclonal Antibody

Anti-Cdc37 Antibody. Tested in WB applications. This antibody reacts with Human.

Product Specifications

Product Name Alternative

Hsp90 co-chaperone Cdc37; Hsp90 chaperone protein kinase-targeting subunit; p50Cdc37; Hsp90 co-chaperone Cdc37, N-terminally processed; CDC37; CDC37A

UniProt

Q16543

Reactivity

Human

Cross Reactivity

No cross-reactivity with other proteins

Immunogen

A synthetic peptide corresponding to a sequence at the C-terminus of human Cdc37, different from the related mouse sequence by two amino acids, and from the related rat sequence by three amino acids.

Target

Hsp90 co-chaperone Cdc37

Clonality

Polyclonal

Conjugation

Unconjugated

Field of Research

Cell Biology, Epigenetics & Chromatin, Protein Biochemistry

Purification

Immunogen affinity purified.

Concentration

Adding 0.2 ml of distilled water will yield a concentration of 500 μg/ml.

Dilution

Western blot, 0.1-0.5μg/ml, Human

Form

Lyophilized

Molecular Weight

44 kDa

Storage Conditions

Maintain refrigerated at 2-8°C for up to 2 weeks. For long term storage store at -20°C in small aliquots to prevent freeze-thaw cycles.

Notes

For research use only.

Tested Applications

WB

Host or Source

Rabbit

Preservative

Each vial contains antibody formulated with stabilizing components, 0.9mg NaCl, 0.2mg Na2HPO4, 0.05mg Thimerosal, 0.05mg NaN3. *This antibody is supplied in a stabilized formulation. Compatibility with conjugation reactions depends on the chemistry of the conjugation method used. For conjugation methods that are not compatible with the stabilizing components present in this formulation, a carrier-free antibody format is required.